Evidence map›Paper›PMID 33567701›Full record

Trial reportNutrients2021

Effects of Synbiotic Supplementation on Chronic Inflammation and the Gut Microbiota in Obese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Study.

Akio Kanazawa, Masanori Aida, Yasuto Yoshida, Hideyoshi Kaga, Takehiro Katahira, Luka Suzuki, Shoko Tamaki, Junko Sato, Hiromasa Goto, Kosuke Azuma and 4 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 13 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 13 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 13 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Effects ofFrontiers in microbiology · 2025
    Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Akio KanazawaDepartment of Metabolism & Endocrinology, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan.ORCID 0000-0003-2292-395X
Masanori AidaFood Research Department, Yakult Central Institute, Tokyo 186-8650, Japan.
Yasuto YoshidaFood Research Department, Yakult Central Institute, Tokyo 186-8650, Japan.ORCID 0000-0002-7881-8297
Hideyoshi KagaDepartment of Metabolism & Endocrinology, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan.
Takehiro KatahiraDepartment of Metabolism & Endocrinology, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan.
Luka SuzukiDepartment of Metabolism & Endocrinology, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan.
Shoko TamakiDepartment of Metabolism & Endocrinology, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan.
Junko SatoDepartment of Metabolism & Endocrinology, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan.
Hiromasa GotoDepartment of Metabolism & Endocrinology, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan.
Kosuke AzumaDepartment of Metabolism & Endocrinology, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan.
Tomoaki ShimizuDepartment of Metabolism & Endocrinology, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan.
Takuya TakahashiYakult Honsha European Research Center for Microbiology, 9052 Gent-Zwijnaarde, Belgium.
Yuichiro YamashiroProbiotics Research Laboratory, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan.
Hirotaka WatadaDepartment of Metabolism & Endocrinology, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan.

Funding

Yakult Honsha Co., Ltd. 17-283
6 · The paper itself

Abstract

The aim of this study was to investigate the effects of 24-week synbiotic supplementation on chronic inflammation and the gut microbiota in obese patients with type 2 diabetes. We randomized 88 obese patients with type 2 diabetes to one of two groups for 24 weeks: control or synbiotic (

Indexed as

AgedBifidobacterium breveChronic DiseaseC-Reactive ProteinDiabetes Mellitus, Type 2FecesFemaleGastrointestinal MicrobiomeHumansInflammationInflammation MediatorsLacticaseibacillus caseiMaleMiddle AgedObesitySynbioticsC-Reactive ProteinInflammation Mediatorschronic inflammationgalacto-oligosccharides (GOSs)gut microbiotaprobioticsynbiotictype 2 diabetes

Identifiers

PMID33567701
PMCPMC7914668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.